These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 6352137)

  • 21. Pharmacokinetic model of presystemic metabolism.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(2):193-6. PubMed ID: 26536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presystemic elimination of drugs: theoretical considerations for quantifying the relative contribution of gut and liver.
    Minchin RF; Ilett KF
    J Pharm Sci; 1982 Apr; 71(4):458-60. PubMed ID: 7086660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
    Verbeeck RK
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of diet and nutritional status on drug metabolism.
    Walter-Sack I; Klotz U
    Clin Pharmacokinet; 1996 Jul; 31(1):47-64. PubMed ID: 8827399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extraction.
    Corbett H; Cahill CM; Heinzow B; Harrison PM; Byrne AJ; McLean AJ
    J Pharmacol Exp Ther; 1986 Nov; 239(2):517-21. PubMed ID: 3772806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data.
    Somogyi A; Eichelbaum M; Gugler R
    Eur J Clin Pharmacol; 1982; 22(1):85-90. PubMed ID: 7094978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.
    Franco V; Gershkovich P; Perucca E; Bialer M
    Clin Pharmacokinet; 2020 Dec; 59(12):1493-1500. PubMed ID: 32785853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
    Grundy JS; Foster RT
    Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
    Pedersen AK; FitzGerald GA
    N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of the bioavailability of propranolol and metoprolol by food.
    Melander A; Danielson K; Scherstén B; Wåhlin E
    Clin Pharmacol Ther; 1977 Jul; 22(1):108-12. PubMed ID: 872491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
    Rubin GM; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug dosing in chronic hepatic disease (author's transl)].
    Gugler R; Eichelbaum M
    Leber Magen Darm; 1981 Apr; 11(2):81-7. PubMed ID: 7015045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presystemic drug elimination.
    Routledge PA; Shand DG
    Annu Rev Pharmacol Toxicol; 1979; 19():447-68. PubMed ID: 378106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of food on the presystemic metabolism of drugs.
    Melander A; Lalka D; McLean A
    Pharmacol Ther; 1988; 38(2):253-67. PubMed ID: 3054941
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions and non-interactions with ranitidine.
    Kirch W; Hoensch H; Janisch HD
    Clin Pharmacokinet; 1984; 9(6):493-510. PubMed ID: 6096071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism.
    Aungst BJ
    J Pharm Sci; 1993 Oct; 82(10):979-87. PubMed ID: 8254497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of food on propranolol oral clearance and a possible mechanism of this food effect.
    Ogiso T; Iwaki M; Tanino T; Kawafuchi R; Hata S
    Biol Pharm Bull; 1994 Jan; 17(1):112-6. PubMed ID: 8148797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between the systemic clearance of drugs and their food effects in humans.
    Marasanapalle VP; Boinpally RR; Zhu H; Grill A; Tang F
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1311-7. PubMed ID: 21692649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of food on drug bioavailability.
    Toothaker RD; Welling PG
    Annu Rev Pharmacol Toxicol; 1980; 20():173-99. PubMed ID: 6992698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.